Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Thank you for providing this information and showing that the safety issue for Celgene product didn't just appear out of the blue in Phase III. We all know this type of trial result can happen, but most would expect, as with your explanation, that some indication of safety issues would have occurred prior to the Phase III.

I don't think any believer in IPIX products discounts totally safety issues as a risk for our current 3 products in trials, it is just that at this point in their clinical trials they have proven so far to be remarkably safe and have given us confidence that the odds are better than most other drugs that they will continue with no trial ending safety issues.

Hope data results prove us correct.